Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Consolidated net loss	$ (1,533)	$ (153)
Adjustments to reconcile consolidated net loss to net cash used in operating activities:
Loss from discontinued operations	430	4,537
Depreciation	2,611	3,080
Amortization of intangible assets	67	0
Deferred income tax expense	2,413	2,516
Provision for (recovery on) doubtful receivables	(65)	712
Share-based compensation expense	7,420	3,669
Amortization of debt costs	285	513
Other, net	195	208
Changes in operating assets and liabilities:
Accounts receivable	(8,413)	(16,157)
Other current and long-term assets	2,040	(470)
Accounts payable	(7,129)	793
Accrued compensation and related liabilities	(17,195)	(13,759)
Other current and long-term liabilities	(5,985)	(1,914)
Income taxes payable/refundable	(2,391)	(738)
Cash used in operating activities — continuing operations	(27,250)	(17,163)
Cash used in operating activities — discontinued operations	(779)	(3,367)
Cash used in operating activities	(28,029)	(20,530)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition	(845)	0
Purchases of property and equipment, net	(5,009)	(1,286)
Cash used in investing activities — continuing operations	(5,854)	(1,286)
Cash used in investing activities — discontinued operations	0	(313)
Cash used in investing activities	(5,854)	(1,599)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings on long-term debt	157,869	146,987
Payments on long-term debt	(150,414)	(144,274)
Employee stock purchases and options exercised	4,373	1,625
Purchase of shares for employee tax withholdings	(2,675)	(429)
Payment of initial fair value of acquisition-related contingent consideration	0	(3,428)
Cash provided by financing activities — continuing operations	9,153	481
Effect of foreign exchange rate changes on cash and cash equivalents	611	(3,580)
Net decrease in cash and cash equivalents	(24,119)	(25,228)
Cash and cash equivalents, beginning of period	44,483	58,849
Cash and cash equivalents, end of period	$ 20,364	$ 33,621